High-Density Lipoproteins Suppress Chemokines and Chemokine Receptors In Vitro and In Vivo

OBJECTIVE—To investigate whether high-density lipoproteins (HDLs) suppress chemokine (CCL2, CCL5, and CX3CL1) and chemokine receptor (CCR2 and CX3CR1) expression, a mechanism for the atheroprotective properties of HDLs. METHODS AND RESULTS—Apolipoprotein (apo) E mice were fed a high-fat diet for 12...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2010-09, Vol.30 (9), p.1773-1778
Hauptverfasser: Bursill, Christina A, Castro, Maria L, Beattie, Douglas T, Nakhla, Shirley, van der Vorst, Emiel, Heather, Alison K, Barter, Philip J, Rye, Kerry-Anne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVE—To investigate whether high-density lipoproteins (HDLs) suppress chemokine (CCL2, CCL5, and CX3CL1) and chemokine receptor (CCR2 and CX3CR1) expression, a mechanism for the atheroprotective properties of HDLs. METHODS AND RESULTS—Apolipoprotein (apo) E mice were fed a high-fat diet for 12 weeks. Before being euthanized, the mice received 5 consecutive daily injections of lipid-free apoA-I, 40 mg/kg, or saline (control). The injection of apoA-I reduced CCR2 and CX3CR1 expression in plaques compared with controls (P
ISSN:1079-5642
1524-4636
DOI:10.1161/ATVBAHA.110.211342